Incidence rate and time to serious adverse events among rifampicin resistant tuberculosis patients in Georgia treated with new and repurposed anti-tuberculosis drugs, 2016-2018
Published: January 14, 2021
Abstract Views: 1514
PDF: 778
Supplementary: 124
Supplementary: 124
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- Giampaolo Scorcu, Annarita Pilleri, Treatment of heart failure in the elderly: Which drugs are essential and which should be avoided , Monaldi Archives for Chest Disease: Vol. 88 No. 2 (2018)
- Raffaele Griffo, Pier Luigi Temporelli, Francesco Fattirolli, Francesco Fattirolli, Marco Ambrosetti, Roberto Tramarin, Anna Rita Vestri, Stefania De Feo, Luigi Tavazzi, ICAROS (Italian survey on CardiAc RehabilitatiOn and Secondary prevention after cardiac revascularization): temporary report of the first prospective, longitudinal registry of the cardiac rehabilitation network GICR/IACPR , Monaldi Archives for Chest Disease: Vol. 78 No. 2 (2012): Cardiac series
- Deependra Kumar Rai, Surya Kant, Vatsal Bhushan Gupta, Paradoxical reaction in peripheral lymph node tuberculosis: a review for its prevalence, clinical characteristics, and possible treatment , Monaldi Archives for Chest Disease: Early Access
- N. Ambrosino, M. Di Giorgio, A. Di Paco, The patients with severe Chronic Obstructive Pulmonary Disease and chronic respiratory insufficiency , Monaldi Archives for Chest Disease: Vol. 67 No. 3 (2007): Pulmonary series
- Duccio Rossini, Massimo Bulckaen, Stefano Di Marco, Roberto Giovannetti, Franco Giuntoli, Luciana Iacopetti, William Vergoni, Rehabilitation program in patients with moderate-to-severe intermittent claudication: immediate results and one year follow-up , Monaldi Archives for Chest Disease: Vol. 68 No. 2 (2007): Cardiac series
- Laura Casaretti, Stefania Paolillo, Roberto Formisano, Ada Bologna, Giacomo Mattiello, Sirio Conte, Laura Petraglia, Francesco Lo Iudice, Irma Fabiani, Anna Paola Cirillo, Alice Vitagliano, Francesco Gambardella, Giuseppe Luca della Ratta, Pasquale Perrone Filardi, Metabolic and cardiovascular effects of combined antiretroviral therapy in patients with HIV infection. Systematic review of literature , Monaldi Archives for Chest Disease: Vol. 76 No. 4 (2011): Cardiac series
- R. Agarwal, N. Singh, A.N. Aggarwal, An unusual association between Mycobacterium tuberculosis and Aspergillus fumigatus , Monaldi Archives for Chest Disease: Vol. 69 No. 1 (2008): Pulmonary series
- Y. Lacasse, L. Beaudoin, L. Rousseau, F. Maltais, Randomized trial of paroxetine in end-stage COPD , Monaldi Archives for Chest Disease: Vol. 61 No. 3 (2004): Pulmonary series
- L. Casali, G. Pinchi, E. Puxeddu, Doping and Respiratory System , Monaldi Archives for Chest Disease: Vol. 67 No. 1 (2007): Pulmonary series
- Roberto Valle, Nadia Aspromonte, Emanuele Carbonieri, Giorgio De Michele, Giuseppe Di Tano, Prospero Giovinazzo, Roberta Cioè, Tiziana Di Giacomo, Loredano Milani, Federica Noventa, Mario Chiatto, BNP-guided therapy optimizes the timing of discharge and the medium term risk stratification in patients admitted for congestive heart failure , Monaldi Archives for Chest Disease: Vol. 68 No. 3 (2007): Cardiac series
<< < 2 3 4 5 6 7 8 9 10 11 > >>
You may also start an advanced similarity search for this article.